Editor: Atta-ur-Rahman

Topics in Anti-Cancer Research

Volume 10

eBook: US $71 Special Offer (PDF + Printed Copy): US $123
Printed Copy: US $87
Library License: US $284
ISSN: 2468-5860 (Print)
ISSN: 2213-3585 (Online)
ISBN: 978-981-5039-30-6 (Print)
ISBN: 978-981-5039-29-0 (Online)
Year of Publication: 2021
DOI: 10.2174/97898150392901211001


Topics in Anti-Cancer Research covers new developments in the field of cancer diagnosis and drug therapy. Novel drugs as anticancer agents include natural and synthetic phenazirines and other anti-cancer compounds. The series also covers information on the current understanding of the pathology and molecular biology of specific neoplasms.

The diversity of research topics published in this book series give broad and valuable perspectives for cancer researchers, clinicians, cancer professionals aiming to develop novel anti-cancer targets and patents for the treatment of various cancers.

The topics covered in this volume are:

  • - Peptides can play a major role in combating cancer diseases
  • - Studying of the CLL after treatment using fractal parameter of neoplastic lymphocytes detection (ΛNLD)
  • - Mechanistic insight of rhenium-based compounds as anti- cancer agents
  • - Targeting cancer-specific inflammatory components in cancer therapeutics
  • - Marine natural products as a source of novel anticancer agents: a treasure from the ocean
  • - PDX clinical trial design in anti-cancer research

Audience: Pharmacologists, drug discovery researchers, clinical oncologists, medicinal chemists


The tenth volume of Topics in Anti-Cancer Research covers new developments in the field of cancer. It comprises six comprehensive chapters covering  exciting contributions in frontier areas of anti-cancer research.

Tehrani, in chapter 1, discusses the mechanism of anticancer activity of the peptides that can play a major role in combating cancer diseases. Rezaei and Rostami in chapter 2 of the book, present an appropriate model for investigating the possibility of chronic lymphocytic leukemia (CLL) control using fractal parameter. Veena et al. discuss the mechanistic insight of rhenium-based compounds as anti-cancer agents in the next chapter of the book. Veena et al., in the fourth chapter of the book, provide insights on targeting cancer-specific inflammatory components in cancer therapeutics. Mandlik and Mandlik in the fifth chapter, discuss the anticancer potential of marine natural products in a diversity of flora and fauna, as well as their probable mechanisms of action. In the last chapter, Kajbafzadeh et al. address patient-derived xenograft (PDX) clinical trial designs in anti-cancer research.

I am thankful to the authors for their excellent contributions and to the reviewers for their in-depth and comprehensive comments for the improvement of the chapters. I am also grateful to Mr. Mahmood Alam (Editorial Director), Mr. Obaid Sadiq (Incharge Books Department), Ms. Asma Ahmed (Senior Manager Publications) and other colleagues for their support and assistance in the finalization of this volume.

Atta-ur-Rahman, FRS

Kings College
University of Cambridge